| 查看: 26813 | 回复: 867 | |||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | |||
[交流]
Postdoctoral fellow in Medicinal Chemistry, McGill University
|
|||
|
Postdoctoral fellow in Medicinal Chemistry, McGill University. Project description: This funded project is to develop novel inhibitors of emerging drug targets for lung cancer. Our preliminary work has discovered initial hits, which show selective cytotoxicity against a panel of lung cancer cell lines, with no obvious toxic effects on normal cells. As a key member of our team, the candidate is expected to chemically optimize the initial active compounds (i.e., Hit-to-Lead Optimization). Our laboratory includes three components: Structure-based Drug Design, Medicinal Chemistry and Biological Assays, providing a multidisciplinary environment. We routinely utilize structure-based drug design approaches for hit identification and optimization. The candidate will have the opportunity to be trained in Structure-based Drug Design. Qualifications: We are looking for a candidate who is interested in anticancer drug discovery and determines to develop a life-saving drug. The candidate should have a Ph.D. degree in Organic Chemistry/Medicinal Chemistry, which was obtained in 2025 or 2026. Language required: English Contact: Interested individuals should send a cover letter, updated CV and the coordinates of 2-3 referees to Dr. Jian Hui Wu (email address: jian.h.wu@mcgill.ca). |
回复此楼» 猜你喜欢
售SCI-T0P文章，我:8O.5.5.1.O.54,科目齐全,可+急
已经有4人回复
-
售SCI文章，我:8O5.5.1.O.54,科目齐全,可+急
已经有4人回复
-
售SCI文章，我:8O.5.5.1O.54,科目全,可十急
已经有4人回复
-
售SCI一区T0P文章，我:8.O.55.1.O.5.4,科目全,可+急
已经有4人回复
-
售SCI一区T0P文章，我:8O.55.1.O.5.4,科目齐全,可+急
已经有4人回复
-
售SCI文章，我:8O.5.5.1O.54,科目全,可十急
已经有4人回复
-
售SCI一区T0P文章，我:8O.55.1.O.54,科目全,可伽急
已经有4人回复
-
售SCI文章，我:8O5.5.1.O.54,科目齐全,可+急
已经有4人回复
-
售SCI一区文章，我:8O5.5.1.O5.4,科目全,可伽急
已经有3人回复
-
售SCI-T0P文章，我:8O.5.5.1.O.54,科目齐全,可+急
已经有3人回复
26楼2026-08-14 15:51:38
|
Postdoctoral fellow in Medicinal Chemistry, McGill University Postdoctoral fellow in Medicinal Chemistry, McGill University. Project description: This funded project is to develop novel inhibitors of emerging drug targets for lung cancer. Our preliminary work has discovered initial hits, which show selective cytotoxicity against a panel of lung cancer cell lines, with no obvious toxic effects on normal cells. As a key member of our team, the candidate is expected to chemically optimize the initial active compounds (i.e., Hit-to-Lead Optimization). Our laboratory includes three components: Structure-based Drug Design, Medicinal Chemistry and Biological Assays, providing a multidisciplinary environment. We routinely utilize structure-based drug design approaches for hit identification and optimization. The candidate will have the opportunity to be trained in Structure-based Drug Design. Qualifications: We are looking for a candidate who is interested in anticancer drug discovery and determines to develop a life-saving drug. The candidate should have a Ph.D. degree in Organic Chemistry/Medicinal Chemistry, which was obtained in 2025 or 2026. Language required: English Contact: Interested individuals should send a cover letter, updated CV and the coordinates of 2-3 referees to Dr. Jian Hui Wu (email address: jian.h.wu@mcgill.ca). |
2楼2026-07-28 10:18:11
简单回复
jiaoxg5楼
2026-07-28 11:06
回复
txh5881(金币+1): 谢谢参与
20